Navigation Links
Caliper and Carestream Settle Lawsuits
Date:8/8/2011

HOPKINTON, Mass., Aug. 8, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that it has favorably settled two lawsuits with Carestream Health, Inc.

In the first lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University alleged that Carestream's marketing and sales of its instrument systems induced infringement of seven imaging patents that are exclusively licensed to Xenogen by Stanford University.  

In the second lawsuit, filed in July 2010, Carestream alleged that Caliper's Lumina XR system infringed a Carestream imaging patent (U.S. Patent No. 7,734,325).

To settle these lawsuits, Carestream and Caliper have agreed (i) to dismiss their respective claims and counterclaims; (ii) that Carestream will not market and sell in-vivo optical imaging systems for certain applications covered by patents licensed from Stanford by Xenogen and Caliper; and (iii) that Carestream will not assert that the Lumina XR system as currently configured and sold by Caliper infringes any of Carestream's patents.

Caliper was represented by Mark Fox Evens and Eldora Ellison, Ph.D. of the law firm Sterne, Kessler, Goldstein & Fox, P.L.L.C.  The two suits are (i) Caliper Life Sciences, et al. v. Carestream Health., Civil Action No.: 4:10-cv-02079-PJH (N.D.Ca.) & (ii) Carestream Health, Inc. v. Caliper Life Sciences, Case No.: 10-cv-00381(WMC)(SLC) (W.D.Wis.).

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently.  Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease.  Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions.  For more information please visit www.caliperLS.com.

Caliper is a registered trademark of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences Reports Second Quarter 2011 Results
2. Caliper Life Sciences to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable
3. Caliper Life Sciences Second Quarter Results Conference Call Notice
4. Caliper Life Sciences to Ring The NASDAQ Stock Market Opening Bell on Tuesday, July 19
5. Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
6. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
7. Caliper Life Sciences to Present at Jefferies 2011 Global Healthcare Conference
8. Caliper Life Sciences to Webcast Investor Session of Open House
9. Caliper Life Sciences Reports First Quarter 2011 Results
10. Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference
11. Caliper Life Sciences First Quarter Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 18, 2017 ... that positive Phase 1 clinical data for Nektar,s lead ... (RCC) were presented at ASCO GU 2017.  NKTR-214 is ... T cells and Natural Killer (NK) cell abundance directly ... on these immune cells.  The results were presented by ...
(Date:2/17/2017)... 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, ... global ablation technologies market is expected to grow at a CAGR ... market is expected to grow at a CAGR of 9.5% from ... and $9.05bn in 2026. ... How this report will benefit you Read on to ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the ... in large part by the Hospital Readmission Reduction Program (HRRP), the return of a ... area for hospitals across the nation. While many providers are struggling to leverage limited ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... over 10 years of research, development and clinical trials, the founder of Chigurupati ... a patented compound of FDA approved ingredients that when infused into alcohol, protect ...
(Date:2/16/2017)... ... February 17, 2017 , ... Teaching nursing care of vulnerable children is ... ACE.P (pediatrics) is being created with the support of the Hearst Foundations. An initiative ... ACE.P will address what has been identified as a critical gap in preparing the ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
Breaking Medicine News(10 mins):